ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · CYH

Atlas market file · Equity · United States

Community Health Systems IncCYH

Last close
2.95
Change
+0.00%
96-bar range
2.41 – 3.92
As of
6 Aug 2026

Community Health Systems Inc is a services-general medical & surgical hospitals, nec issuer listed as CYH on NYSE. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot NYSE:CYH

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

3.96533.56523.1652.76492.364720 Mar29 May06 Aug

up candle   down candle

Latest close2.95
Day change+0.00%
Window high3.92
Window low2.41
96-bar change+2.08%
SnapshotDaily · 96 bars
As of2026-08-06 13:30 UTC

Weekly outlook: the last 104 weekly closes (-41.70% over the window).

6.1542.26619 Aug06 Aug

Source rail: Yahoo Finance chart API (CYH). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for CYH. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

CYH public profile

Company

Services-general medical & surgical hospitals, nec issuer. Community Health Systems Inc is connected to current market context, cited company sources and its retained research file.

Market

Community Health Systems Inc trades as CYH on NYSE. Community Health Systems Inc (CYH) has a latest verified close of 2.95, unchanged, dated 6 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files CYH under USA Stocks, Technology Stocks and Healthcare & Medicine Stocks for browsing.

Institutional Market Wit ● Sourced Research File

Community Health Systems (CYH) tells you it's in the healing business, but its latest 10-Q quietly admits it's also in the charity-care business-at a cost. For the six months ending 30 June 2026, the company forked out an estimated $84 million to treat patients who couldn't pay, up from $69 million a year earlier. That's not a rounding error; it's bigger than the company's entire net income of $70 million for the quarter. The files don't say who got the kindness, but they do say the tab is growing faster than the top line. (source: CYH 10-Q, period ending 2026-06-30, https://www.sec.gov/Archives/edgar/data/1108109/000119312526314196/cyh-20260630.htm)

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for Community Health Systems Inc today

Open full report
CYH daily contextvalidated public digest13 source rail2026-08-07 02:40 UTC

Community Health Systems (CYH) is a Tennessee-based hospital operator whose latest 10-Q reveals a company stretched between its mission and its margins. For the quarter ended 30 June 2026, revenues were $2.83 billion, net income attributable to the parent was $70 million, and diluted EPS sat at $0.51 on 136.5 million shares. The numbers are real, but the optics are telling: the company burned $209 million in operating cash during the quarter while spending $152 million on property, plant, and equipment. That’s a capital-light business only if you ignore the cash-light reality. (source: CYH 10-Q, period ending 2026-06-30, https://www.sec.gov/Archives/edgar/data/1108109/000119312526314196/cyh-20260630.htm)

If you read the investor-facing pages on chs.net, you’ll find community impact reports, press releases, and email sign-ups that paint a picture of robust local care and growing services. The SEC filing, however, tells a quieter story: assets of $12.18 billion sit against liabilities of $13.02 billion, leaving shareholders’ equity at a negative $1.39 billion. The balance sheet reads like a hospital corridor with more exits than entrances. (source: CYH 10-Q, period ending 2026-06-30, https://www.sec.gov/Archives/edgar/data/1108109/000119312526314196/cyh-20260630.htm; CHS community impact report, https://www.chs.net/serving-communities/community-impact-report)

The charity-care line is the quiet elephant in the room. For the six months ended 30 June 2026, the company estimates it provided $84 million in charity care, up from $69 million in the prior-year period. The 10-Q confirms the tab is growing faster than revenue, and it arrives with no matching revenue to offset it. That’s corporate philanthropy you can’t audit away. (source: CYH 10-Q, period ending 2026-06-30, https://www.sec.gov/Archives/edgar/data/1108109/000119312526314196/cyh-20260630.htm)

The company’s cash balance is a modest $149 million, its operating cash flow is negative $209 million, and the filing shows no dividend, no buyback, and no meaningful free cash flow. The cash used in operating activities alone is larger than the quarter’s reported profit. In other words, the company’s core business is a net cash consumer, not a generator-at least for now. (source: CYH 10-Q, period ending 2026-06-30, https://www.sec.gov/Archives/edgar/data/1108109/000119312526314196/cyh-20260630.htm)

The management desks’s optics are classic: a glossy investor-relations site, community impact reports, and press releases that sound like a health system on the rise. The SEC filing, however, is the real patient chart: the numbers don’t lie, but the story they tell is one of thin margins, heavy capital demands, and a balance sheet that’s underwater before you add the charity-care liability. The company’s own filings do not provide segment-level detail that would let outsiders know which divisions are carrying the load or dragging the chain, and guidance is absent from the 10-Q. Until the company publishes clearer segment data or cash-flow guidance, the operating reality remains a black box behind the community branding. (source: CYH 10-Q, period ending 2026-06-30, https://www.sec.gov/Archives/edgar/data/1108109/000119312526314196/cyh-20260630.htm; CHS press room, https://www.chs.net/investor-relations/press-room-media-releases)

For those watching the stock, the SEC’s EDGAR index remains the single source of truth. The company’s submissions JSON and companyfacts JSON are the plumbing behind the glossy pages, and they don’t show earnings call transcripts, segment splits, or updated guidance for the balance of 2026. (source: CYH SEC EDGAR filing index, https://www.sec.gov/edgar/browse/?CIK=1108109; CYH SEC submissions JSON, https://data.sec.gov/submissions/CIK0001108109.json; CYH SEC companyfacts JSON, https://data.sec.gov/api/xbrl/companyfacts/CIK0001108109.json)

Sources & evidence · 10 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
CYH
Exchange
NYSE
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView

CYH technical readout

Trend strength (ADX 14)
26.1
Average true range (ATR 14)
0.199
ATR as % of price
7.13%
Volatility compression (ATR14/ATR50)
1.20x

Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

CYH evidence rails

Atlas uses the specific public rails available for CYH: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 5 rails

Open an Atlas research path on CYH

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for CYH Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep CYH research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

CYH FAQ

What is Community Health Systems Inc (CYH)?Community Health Systems Inc (CYH) has a latest verified close of 2.95, unchanged, dated 6 Aug 2026. Use this page to check the price chart, company context,...

Community Health Systems Inc (CYH) has a latest verified close of 2.95, unchanged, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for CYH?Community Health Systems Inc (CYH) has a latest verified close of 2.95, unchanged, dated 6 Aug 2026. It brings the latest available chart, company context, cited...

Community Health Systems Inc (CYH) has a latest verified close of 2.95, unchanged, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files CYH under USA Stocks, Technology Stocks and Healthcare & Medicine Stocks for browsing.

How often is the CYH page updated?The CYH public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The CYH public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for CYH?The CYH file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:CYH. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...

The CYH file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NYSE:CYH. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on CYH?Yes. The workstation can open CYH, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open CYH, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this CYH page investment advice?No. The CYH page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The CYH page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →